Tongue Muscular Assessment in Children (TMAC) - Reproducibility Testing
Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Jun 12, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The Tongue Muscular Assessment in Children (TMAC) study is looking to understand how reliable different testers are when measuring tongue motor skills in children. This means that the researchers want to make sure that when different people evaluate the same child’s tongue movement, they get similar results. The study is currently recruiting children aged between 4 and 17 years who are healthy and do not have any specific medical conditions that could affect their ability to participate.
If your child is eligible, they will be asked to take part in assessments that measure how well their tongue moves. It’s important to note that children with certain health issues, such as eating disorders, neurological disorders, or previous surgeries related to their mouth or throat, will not be able to participate in the study. This trial aims to gather valuable information that could help in understanding tongue motor skills better, which is important for overall health and development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 4 and 17 years old
- Exclusion Criteria:
- • Eating disorder
- • Dysphagia
- • Cardiorespiratory disorder
- • Neurological disorder (including neuromuscular disorders)
- • Previous or ongoing obstructive sleep apnea-hypopnea syndrome
- • Previous or ongoing cancer of the head or neck
- • Previous oral or pharyngeal surgery (except for the surgical removal of wisdom teeth)
- • Cranial, oral or upper airway malformation (ex.: nasal cavities, pharynx)
- • Previous or ongoing orthodontic treatment (e.g. braces)
- • More than 33% of positive answers to the Pediatric Sleep Questionnaire (≥ 8/22)
About Université Catholique De Louvain
Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Woluwe Saint Lambert, Brussels, Belgium
Patients applied
Trial Officials
William Poncin, Prof
Principal Investigator
Université Catholique de Louvain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported